An Opportunity to Revolutionize Point-of-Care Decision Making

Infection diagnosis currently takes 1-3 days to detect. With the ever-increasing number of super bugs and new pathogens infecting humans and animals worldwide, there is an urgent need for a portable, on-site rapid diagnostic that also reports antibiotic resistance/sensitivities.

GeneCapture has validated its proprietary breakthrough solution: CAPTURE™ technology to solve this pressing need and developed a portable medical device to rapidly identify pathogens causing infections in humans. Currently functioning in an automated prototype, with results in an hour, the system identifies highly specific pathogenic DNA/RNA signatures using an inexpensive disposable plastic cartridge. This rapid genetic matching technique has many applications in healthcare, environmental testing, food safety, and bio-warfare identification.

Our mission is to bring ‘infection detection’ out of the lab and directly to the patient location whether that’s at a doctor’s office, an airport, a cruise ship, or a battlefield.

Peggy Sammon
CEO, Founder

Krishnan Chittur, PhD, CTO
Chief Technology Officer, Founder

Greg Thompson
Chief Operation Officer

Paula Koelle
Chief Scientist

Valentine Korman, PhD

All resident associate companies on the HudsonAlpha campus are independently owned and operated.